{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:32:13Z","timestamp":1787002333727,"version":"build-2736575974"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2017,7,6]],"date-time":"2017-07-06T00:00:00Z","timestamp":1499299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,7,6]],"date-time":"2017-07-06T00:00:00Z","timestamp":1499299200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Perinatol"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1038\/jp.2017.92","type":"journal-article","created":{"date-parts":[[2017,7,6]],"date-time":"2017-07-06T09:01:51Z","timestamp":1499331711000},"page":"1003-1009","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Impact of antidepressant treatment during pregnancy on obstetric outcomes among women previously treated for depression: an observational cohort study"],"prefix":"10.1038","volume":"37","author":[{"given":"K K","family":"Venkatesh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V M","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R H","family":"Perlis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A J","family":"Kaimal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,6]]},"reference":[{"issue":"4","key":"BFjp201792_CR1","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1097\/01.AOG.0000116689.75396.5f","volume":"103","author":"HAEA Bennett","year":"2004","unstructured":"Bennett HA EA, Taddio A, Koren G, Einarson TR . Prevalence of depression during pregnancy: systematic review. Obstet Gynecol 2004; 103 (4): 798\u2013709.","journal-title":"Obstet Gynecol"},{"issue":"8","key":"BFjp201792_CR2","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1001\/archpsyc.55.8.694","volume":"55","author":"LLAH Judd","year":"1998","unstructured":"Judd LL AH, Maser JD, Zeller PJ, Endicott J, Coryell W, Paulus MP et al. A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders. Arch Gen Psychiatry 1998; 55 (8): 694\u2013700.","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"BFjp201792_CR3","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1067\/mob.2003.336","volume":"189","author":"L Andersson","year":"2003","unstructured":"Andersson L, Sundstr\u00f6m-Poromaa I, Bixo M, Wulff M, Bondestam K, \u00e5Str\u00f6m M . Point prevalence of psychiatric disorders during the second trimester of pregnancy: a population-based study. Am J Obstet Gynecol 2003; 189 (1): 148\u2013154.","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"BFjp201792_CR4","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1097\/01.AOG.0000287065.59491.70","volume":"110","author":"A Lee","year":"2007","unstructured":"Lee A, Lam SK, Sze Mun Lau SM, Chong CS, Chui HW, Fong DY . Prevalence, course, and risk factors for antenatal anxiety and depression. Obst Gynecol 2007; 110 (5): 1102\u20131112.","journal-title":"Obst Gynecol"},{"issue":"4","key":"BFjp201792_CR5","doi-asserted-by":"publisher","first-page":"e321","DOI":"10.4088\/JCP.12r07968","volume":"74","author":"S Grigoriadis","year":"2013","unstructured":"Grigoriadis S, VonderPorten EH, Mamisashvili L, Tomlinson G, Dennis CL, Koren G et al. The impact of maternal depression during pregnancy on perinatal outcomes: a systematic review and meta-analysis. J Clin Psychiatry 2013; 74 (4): e321\u2013e341.","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"BFjp201792_CR6","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1097\/AOG.0b013e3181ba0632","volume":"114","author":"K Yonkers","year":"2009","unstructured":"Yonkers K, Wisner KL, Stewart DE, Oberlander TF, Dell DL, Stotland N et al. The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. Obstet Gynecol 2009; 114 (3): 703\u2013713.","journal-title":"Obstet Gynecol"},{"issue":"10","key":"BFjp201792_CR7","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1001\/archgenpsychiatry.2010.111","volume":"67","author":"NKBJ Grote","year":"2010","unstructured":"Grote NK BJ, Gavin AR, Melville JL, Iyengar S, Katon WJ . A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction. Arch Gen Psychiatry 2010; 67 (10): 1012\u20131024.","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"BFjp201792_CR8","doi-asserted-by":"publisher","first-page":"e0119018","DOI":"10.1371\/journal.pone.0119018","volume":"10","author":"R Hu","year":"2015","unstructured":"Hu R, Li Y, Zhang Z, Yan W . Antenatal depressive symptoms and the risk of preeclampsia or operative deliveries: a meta-analysis. PLos ONE 2015; 10 (3): e0119018.","journal-title":"PLos ONE"},{"issue":"1","key":"BFjp201792_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00737-011-0251-1","volume":"15","author":"D Davalos","year":"2012","unstructured":"Davalos D, Yadon CA, Tregellas HC . Untreated prenatal maternal depression and the potential risks to offspring: a review. Arch Womens Mental Health 2012; 15 (1): 1\u201314.","journal-title":"Arch Womens Mental Health"},{"issue":"9","key":"BFjp201792_CR10","doi-asserted-by":"publisher","first-page":"960","DOI":"10.3109\/14767058.2013.845157","volume":"27","author":"K Szegda","year":"2014","unstructured":"Szegda K, Markenson G, Bertone-Johnson ER, Chasan-Taber L . Depression during pregnancy: a risk factor for adverse neonatal outcomes? A critical review of the literature. J Matern Fetal Neonatal Med 2014; 27 (9): 960\u2013967.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"10","key":"BFjp201792_CR11","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1176\/appi.ajp.2007.06111893","volume":"164","author":"P Dietz","year":"2007","unstructured":"Dietz P, Williams SB, Callaghan WM, Bachman DJ, Whitlock EP, Hornbrook MC . Clinically identified maternal depression before, during, and after pregnancies ending in live births. Am J Psychiatry 2007; 164 (10): 1515\u20131520.","journal-title":"Am J Psychiatry"},{"issue":"1","key":"BFjp201792_CR12","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ajog.2012.04.028","volume":"207","author":"R Hayes","year":"2012","unstructured":"Hayes R, Wu P, Shelton RC, Cooper WO, Dupont WD, Mitchel E et al. Maternal antidepressant use and adverse outcomes: a cohort study of 228,876 pregnancies. Am J Obstet Gynecol 2012; 207 (1): 49.","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"BFjp201792_CR13","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1111\/j.1471-0528.2007.01387.x","volume":"114","author":"EOD Ramosn","year":"2007","unstructured":"Ramosn E OD, Rey E, Blais L, B\u00e9rard A . Prevalence and predictors of antidepressant use in a cohort of pregnant women. BJOG 2007; 114 (9): 1055\u20131064.","journal-title":"BJOG"},{"issue":"8","key":"BFjp201792_CR14","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1001\/archpsyc.63.8.898","volume":"63","author":"T Oberlander","year":"2006","unstructured":"Oberlander T, Warburton W, Misri S, Aghajanian J, Hertzman C . Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data. Arch Gen Psychiatry 2006; 63 (8): 898\u2013906.","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"BFjp201792_CR15","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.ajog.2006.02.019","volume":"194","author":"S Wen","year":"2006","unstructured":"Wen S, Yang Q, Garner P, Fraser W, Olatunbosun O, Nimrod C et al. Selective serotonin reuptake inhibitors and adverse pregnancy outcomes. Am J Obstet Gynecol 2006; 194 (4): 961\u2013966.","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"BFjp201792_CR16","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1176\/appi.ajp.2012.12081126","volume":"169","author":"M Steiner","year":"2012","unstructured":"Steiner M . Prenatal exposure to antidepressants: how safe are they? Am J Psychiatry 2012; 169 (11): 1130\u20131132.","journal-title":"Am J Psychiatry"},{"issue":"4","key":"BFjp201792_CR17","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1001\/jamapsychiatry.2013.684","volume":"70","author":"LEGS Ross","year":"2013","unstructured":"Ross LE GS, Mamisashvili L, Vonderporten EH, Roerecke M, Rehm J, Dennis CL et al. Selected pregnancy and delivery outcomes after exposure to antidepressant medication: a systematic review and meta-analysis. JAMA Psychiatry 2013; 70 (4): 436\u2013443.","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"BFjp201792_CR18","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/j.1471-0528.2007.01518.x","volume":"115","author":"S Maschi","year":"2008","unstructured":"Maschi S, Clavenna A, Campi R, Schiavetti B, Bernat M, Bonati M . Neonatal outcome following pregnancy exposure to antidepressants: a prospective controlled cohort study. BJOG 2008; 115 (2): 283\u2013289.","journal-title":"BJOG"},{"issue":"1","key":"BFjp201792_CR19","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.genhosppsych.2013.08.002","volume":"36","author":"H Huang","year":"2014","unstructured":"Huang H, Coleman S, Bridge JA, Yonkers K, Katon W . A meta-analysis of the relationship between antidepressant use in pregnancy and the risk of preterm birth and low birth weight. Gen Hosp Psychiatry 2014; 36 (1): 13\u201318.","journal-title":"Gen Hosp Psychiatry"},{"issue":"3","key":"BFjp201792_CR20","doi-asserted-by":"publisher","first-page":"e92778","DOI":"10.1371\/journal.pone.0092778","volume":"9","author":"K Huybrechts","year":"2014","unstructured":"Huybrechts K, Sanghani RS, Avorn J, Urato AC . Preterm birth and antidepressant medication use during pregnancy: a systematic review and meta-analysis. PLos ONE 2014; 9 (3): e92778.","journal-title":"PLos ONE"},{"issue":"12","key":"BFjp201792_CR21","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1111\/1471-0528.14144","volume":"123","author":"A Eke","year":"2016","unstructured":"Eke A, Saccone G, Berghella V . Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and risk of preterm birth: a systematic review and meta-analysis. BJOG 2016; 123 (12): 1900\u20131907.","journal-title":"BJOG"},{"issue":"3","key":"BFjp201792_CR22","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.ajog.2004.09.027","volume":"192","author":"B Chun-Fai-Chan","year":"2005","unstructured":"Chun-Fai-Chan B, Koren G, Fayez I, Kalra S, Voyer-Lavigne S, Boshier A et al. Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study. Am J Obstet Gynecol 2005; 192 (3): 932\u2013936.","journal-title":"Am J Obstet Gynecol"},{"issue":"12","key":"BFjp201792_CR23","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1176\/appi.ajp.159.12.2055","volume":"159","author":"G Simon","year":"2002","unstructured":"Simon G, Cunningham ML, Davis RL . Outcomes of prenatal antidepressant exposure. Am J Psychiatry 2002; 159 (12): 2055\u20132061.","journal-title":"Am J Psychiatry"},{"issue":"8","key":"BFjp201792_CR24","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1176\/appi.ajp.2007.06071172","volume":"164","author":"R Suri","year":"2007","unstructured":"Suri R, Altshuler L, Hellemann G, Burt VK, Aquino A, Mintz J . Effects of antenatal depression and antidepressant treatment on gestational age at birth and risk of preterm birth. Am J Psychiatry 2007; 164 (8): 1206\u20131213.","journal-title":"Am J Psychiatry"},{"issue":"9","key":"BFjp201792_CR25","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1093\/aje\/kwf131","volume":"156","author":"S Orr","year":"2002","unstructured":"Orr S, James SA, Blackmore Prince C . Maternal prenatal depressive symptoms and spontaneous preterm births among African-American women in Baltimore, Maryland. Am J Epidemiol 2002; 156 (9): 797\u2013802.","journal-title":"Am J Epidemiol"},{"issue":"5","key":"BFjp201792_CR26","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1097\/EDE.0b013e318258fbb2","volume":"23","author":"K Palmsten","year":"2012","unstructured":"Palmsten K, Hern\u00e1ndez-D\u00edaz S . Can nonrandomized studies on the safety of antidepressants during pregnancy convincingly beat confounding, chance, and prior beliefs? Epidemiology 2012; 23 (5): 686\u2013688.","journal-title":"Epidemiology"},{"issue":"1","key":"BFjp201792_CR27","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1136\/eb-2012-101164","volume":"17","author":"E Accortt","year":"2014","unstructured":"Accortt E, Schetter CD . Pregnant women screening positive for depressive symptoms at 24-28 weeks may have increased risk of preterm birth but more precise research is needed. Evid Based Nurs 2014; 17 (1): 11\u201312.","journal-title":"Evid Based Nurs"},{"issue":"5","key":"BFjp201792_CR28","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1176\/appi.ajp.2008.08081170","volume":"166","author":"K Wisner","year":"2009","unstructured":"Wisner K, Sit DK, Hanusa BH, Moses-Kolko EL, Bogen DL, Hunker DF et al. Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes. Am J Psychiatry 2009; 166 (5): 557\u2013566.","journal-title":"Am J Psychiatry"},{"issue":"5","key":"BFjp201792_CR29","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1192\/bjp.bp.107.037101","volume":"192","author":"T Oberlander","year":"2008","unstructured":"Oberlander T, Warburton W, Misri S, Aghajanian J, Hertzman C . Effects of timing and duration of gestational exposure to serotonin reuptake inhibitor antidepressants: population-based study. Br J Psychiatry 2008; 192 (5): 338\u2013343.","journal-title":"Br J Psychiatry"},{"issue":"14","key":"BFjp201792_CR30","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1056\/NEJM199610033351402","volume":"335","author":"C Chambers","year":"1996","unstructured":"Chambers C, Johnson KA, Dick LM, Felix RJ, Jones KL . Birth outcomes in pregnant women taking fluoxetine. N Engl J Med 1996; 335 (14): 1010\u20131015.","journal-title":"N Engl J Med"},{"issue":"6","key":"BFjp201792_CR31","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1097\/DBP.0000000000000188","volume":"36","author":"M Uchida","year":"2015","unstructured":"Uchida M, Spencer AE, Biederman J, Castro VM, Kenworthy T, Chan J et al. A systematic evaluation of the qtc interval and antidepressants in youth: An Electronic Health Record Study. J Dev Behav Pediatr 2015; 36 (6): 434\u2013439.","journal-title":"J Dev Behav Pediatr"},{"issue":"8","key":"BFjp201792_CR32","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1001\/jamapsychiatry.2014.414","volume":"71","author":"S Blumenthal","year":"2014","unstructured":"Blumenthal S, Castro VM, Clements CC, Rosenfield HR, Murphy SN, Fava M et al. An electronic health records study of long-term weight gain following antidepressant use. JAMA Psychiatry 2014; 71 (8): 889\u2013896.","journal-title":"JAMA Psychiatry"},{"key":"BFjp201792_CR33","volume-title":"Household Income: 2013","author":"UC Bureau","year":"2014","unstructured":"Bureau UC . Household Income: 2013. American Community Survvey Briefs, United States Dept of Commerce, US Census Bureau 2014 Website: https:\/\/www.census.gov\/content\/dam\/Census\/library\/publications\/2014\/acs\/acsbr13-02.pdf. Access date 11\/1\/2016."},{"issue":"6","key":"BFjp201792_CR34","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/mp.2014.90","volume":"20","author":"C Clements","year":"2015","unstructured":"Clements C, Castro VM, Blumenthal SR, Rosenfield HR, Murphy SN, Fava M et al. Prenatal antidepressant exposure is associated with risk for attention-deficit hyperactivity disorder but not autism spectrum disorder in a large health system. Mol Psychiatry 2015; 20 (6): 727\u2013734.","journal-title":"Mol Psychiatry"},{"key":"BFjp201792_CR35","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1471-2431-3-6","volume":"3","author":"E Oken","year":"2003","unstructured":"Oken E, Kleinman KP, Rich-Edwards J, Gillman MW . A nearly continuous measure of birth weight for gestational age using a United States national reference. BMC Pediatr 2003; 3: 6.","journal-title":"BMC Pediatr"},{"issue":"5","key":"BFjp201792_CR36","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1097\/EDE.0b013e31825838e9","volume":"23","author":"K Yonkers","year":"2012","unstructured":"Yonkers K, Norwitz ER, Smith MV, Lockwood CJ, Gotman N, Luchansky E et al. Depression and serotonin reuptake inhibitor treatment as risk factors for preterm birth. Epidemiology 2012; 23 (5): 677\u2013685.","journal-title":"Epidemiology"},{"key":"BFjp201792_CR37","volume-title":"Maternal Depression in Pregnancy and its Association with Adverse Pregnancy Outcomes","author":"A Fong","year":"2017","unstructured":"Fong A, Simon-Freeman R, Westermann M, Pan D, Ogunyemi DA . Maternal Depression in Pregnancy and its Association with Adverse Pregnancy Outcomes. Society of Maternal Fetal Medicine 37th Annual Meeting; 2017 American Journal of Obstetrics and Gynecology: Las Vegas, NV, USA, 2017."},{"issue":"6","key":"BFjp201792_CR38","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1093\/aje\/kwp437","volume":"171","author":"Y Cheng","year":"2010","unstructured":"Cheng Y, Hubbard A, Caughey AB, Tager IB . The association between persistent fetal occiput posterior position and perinatal outcomes: an example of propensity score and covariate distance matching. Am J Epidemiol 2010; 171 (6): 656\u2013663.","journal-title":"Am J Epidemiol"},{"key":"BFjp201792_CR39","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/j.1468-0262.2006.00655.x","volume":"74","author":"A Abadie","year":"2006","unstructured":"Abadie A, Imbens GW . Large sample properties of matching estimators for average treatment effects. Econometrica 2006; 74: 235\u2013267.","journal-title":"Econometrica"},{"issue":"5","key":"BFjp201792_CR40","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1111\/1475-6773.12182","volume":"49","author":"M Garrido","year":"2014","unstructured":"Garrido M, Kelley AS, Paris J, Roza K, Meier DE, Morrison RS et al. Methods for constructing and assessing propensity scores. Health Serv Res 2014; 49 (5): 1701\u20131720.","journal-title":"Health Serv Res"},{"issue":"4","key":"BFjp201792_CR41","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1111\/1475-6773.12020","volume":"48","author":"J Brooks","year":"2013","unstructured":"Brooks J, Ohsfeldt RL . Squeezing the balloon: propensity scores and unmeasured covariate balance. Health Serv Res 2013; 48 (4): 1487\u20131507.","journal-title":"Health Serv Res"},{"issue":"1","key":"BFjp201792_CR42","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1162\/003465304323023651","volume":"86","author":"G Imbens","year":"2004","unstructured":"Imbens G . Nonparametric estimation of average treatment effects under exogeneity: a review. Rev Econ Stat 2004; 86 (1): 4\u201329.","journal-title":"Rev Econ Stat"},{"issue":"2","key":"BFjp201792_CR43","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/pst.433","volume":"10","author":"P Austin","year":"2011","unstructured":"Austin P . Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat 2011; 10 (2): 150\u2013161.","journal-title":"Pharm Stat"},{"issue":"8","key":"BFjp201792_CR44","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.4088\/JCP.v68n0817","volume":"68","author":"K Pearson","year":"2007","unstructured":"Pearson K, Nonacs RM, Viguera AC, Heller VL, Petrillo LF, Brandes M et al. Birth outcomes following prenatal exposure to antidepressants. J Clin Psychiatry 2007; 68 (8): 1284\u20131289.","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"BFjp201792_CR45","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1097\/01.AOG.0000187302.61812.53","volume":"106","author":"H Malm","year":"2005","unstructured":"Malm H, Klaukka T, Neuvonen PJ . Risks associated with selective serotonin reuptake inhibitors in pregnancy. Obstet Gynecol 2005; 106 (6): 1289\u20131296.","journal-title":"Obstet Gynecol"},{"issue":"7","key":"BFjp201792_CR46","first-page":"706","volume":"69","author":"H El Marroun","year":"2011","unstructured":"El Marroun H, Jaddoe VW, Hudziak JJ, Roza SJ, Steegers EA, Hofman A et al. Maternal use of selective serotonin reuptake inhibitors, fetal growth, and risk of adverse birth outcomes. Arch Gen Psychiatry 2011; 69 (7): 706\u2013714.","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"BFjp201792_CR47","doi-asserted-by":"publisher","first-page":"291","DOI":"10.4088\/JCP.08ac04976","volume":"70","author":"M Freeman","year":"2009","unstructured":"Freeman M . Breastfeeding and antidepressants: clinical dilemmas and expert perspectives. J Clin Psychiatry 2009; 70 (2): 291\u2013292.","journal-title":"J Clin Psychiatry"},{"issue":"9","key":"BFjp201792_CR48","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1093\/pch\/16.9.562","volume":"16","author":"Jefferies ACPS","year":"2011","unstructured":"ACPS Jefferies Fetus and Newborn Committee. Selective serotonin reuptake inhibitors in pregnancy and infant outcomes. Paediatr Child Health 2011; 16 (9): 562\u2013563.","journal-title":"Paediatr Child Health"},{"issue":"2","key":"BFjp201792_CR49","doi-asserted-by":"publisher","first-page":"230","DOI":"10.4088\/JCP.v65n0214","volume":"65","author":"T Oberlander","year":"2004","unstructured":"Oberlander T, Misri S, Fitzgerald CE, Kostaras X, Rurak D, Riggs W . Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure. J Clin Psychiatry 2004; 65 (2): 230\u2013237.","journal-title":"J Clin Psychiatry"},{"issue":"9","key":"BFjp201792_CR50","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/sj.jp.7211352","volume":"25","author":"K Lattimore","year":"2005","unstructured":"Lattimore K, Donn SM, Kaciroti N, Kemper AR, Neal CR Jr, Vazquez DM . Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and effects on the fetus and newborn: a meta-analysis. J Perinatol 2005; 25 (9): 595\u2013604.","journal-title":"J Perinatol"},{"issue":"3","key":"BFjp201792_CR51","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ajog.2012.02.009","volume":"207","author":"G Koren","year":"2012","unstructured":"Koren G, Nordeng H . Antidepressant use during pregnancy: the benefit-risk ratio. Am J Obstet Gynecol 2012; 207 (3): 157\u2013163.","journal-title":"Am J Obstet Gynecol"}],"container-title":["Journal of Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/jp201792.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/jp201792","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/jp.2017.92","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/jp201792.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T12:20:30Z","timestamp":1647606030000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/jp201792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,6]]},"references-count":51,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["BFjp201792"],"URL":"https:\/\/doi.org\/10.1038\/jp.2017.92","relation":{},"ISSN":["0743-8346","1476-5543"],"issn-type":[{"value":"0743-8346","type":"print"},{"value":"1476-5543","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,6]]},"assertion":[{"value":"29 January 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"PRH has received consultant fees or served on scientific advisory boards for Proteus Biomedical, Genomind, Healthrageous, Perfect Health, and Psy Therapeutics. The remaining authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}